Natural Grocers (NGVC) Insider Notice: 500 Shares for Sale via Apex Clearing

Rhea-AI Filing Summary

Natural Grocers by Vitamin Cottage, Inc. (NGVC) notice reports a proposed sale of 500 shares of common stock through Apex Clearing on the NYSE with an aggregate market value of $20,270. The shares were acquired as an issuer stock grant on 07/30/2012 totaling 49,365 shares received at that time; payment was recorded as N/A. The filer, identified as Lark Isely, previously sold 2,000 shares on 06/11/2025 for $88,520 and 2,000 shares on 08/19/2025 for $80,000. The notice includes a declaration that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of the origin of shares (issuer stock grant dated 07/30/2012)
• Prior sales disclosed, showing consistent reporting of recent dispositions (4,000 shares in 2025 totaling $168,520)
• Small proposed sale (500 shares, $20,270), which is immaterial relative to the reported 22,954,109 shares outstanding

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider filing shows a small, routine sale from long-held issuer grant; recent prior sales indicate partial liquidity activity.

The filing documents a proposed sale of 500 shares (~$20.3k) originating from a 2012 issuer stock grant. Prior open-market dispositions by the same person totaled 4,000 shares in 2025, generating ~$168.5k, indicating ongoing monetization of an existing holding rather than a large, dilutive event. No new material information about the company is disclosed and the transaction size is immaterial relative to the issuer's outstanding share count of 22,954,109 as reported here. Impact on investors is limited; this is a routine Rule 144 notice to enable compliant resale.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure with standard attestation; no governance red flags disclosed.

The filer affirms lack of undisclosed material adverse information and references Rule 144 and potential Rule 10b5-1 plans. The document provides provenance of the securities (issuer grant) and prior sales, which supports transparency. There is no indication of accelerated insider selling or governance disputes. From a governance perspective, the filing meets routine disclosure expectations and does not signal immediate corporate control changes or compliance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	APEX CLEARING 350 N ST. PAUL ST, SUITE 300 DALLAS TX 75201	500	20270.00	22954109	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/30/2012	Issuer Stock Grant	Natural Grocers by Vitamin Cottage, Inc.			49365	07/30/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lark Isely 26 Lewis Peak Road Waitsburg WA 99361	Common Stock	06/11/2025	2000	88520.00
Lark Isely 26 Lewis Peak Road Waitsburg WA 99361	Common Stock	08/19/2025	2000	80000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for NGVC indicate?

The Form 144 indicates a proposed sale of 500 shares of NGVC common stock through Apex Clearing on the NYSE with an aggregate market value of $20,270.

Who is the filer and what prior sales are disclosed?

The filer is identified as Lark Isely; prior disclosed sales in 2025 were 2,000 shares on 06/11/2025 for $88,520 and 2,000 shares on 08/19/2025 for $80,000.

How were the shares being sold originally acquired?

The shares were acquired via an issuer stock grant from Natural Grocers by Vitamin Cottage, Inc. on 07/30/2012, with 49,365 shares noted as the amount acquired then.

Does the filing disclose any undisclosed material adverse information about NGVC?

The filer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Through which broker will the shares be sold?

The notice lists Apex Clearing, 350 N St. Paul St, Suite 300, Dallas TX 75201 as the broker for the proposed sale.